Additionally, the phosphorylation of its downstream effector Akt, was inhibited, indicating that the disruption of Akt signaling/Akt inactivation plays a functional role in BrMC-mediated cytotoxicity in HER-2/neu-overexpressing breast cancer cells. This evidence concerns the gene AKT1 and breast carcinoma.